Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway.

Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state? Hypertension (2008) 0.75

Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects. PLoS One (2016) 0.75

Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension (2013) 2.82

The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens (2005) 2.46

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens (2005) 2.12

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation (2002) 2.07

Relationship between wave reflection and renal damage in hypertensive patients: a retrospective analysis. J Hypertens (2013) 1.98

Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. J Hypertens (2015) 1.97

The correct administration of antihypertensive drugs according to the principles of clinical pharmacology. Am J Cardiovasc Drugs (2011) 1.92

Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care (2009) 1.91

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. Eur Heart J (2012) 1.91

Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol (2009) 1.81

Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J (2010) 1.67

Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation (2004) 1.65

Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens (2012) 1.62

Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab (2003) 1.61

Endothelium-dependent contractions in hypertension. Br J Pharmacol (2005) 1.59

Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J Hypertens (2002) 1.52

Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49

Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens (2005) 1.49

Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press (2005) 1.49

Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation (2009) 1.49

Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens (2002) 1.48

Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension (2003) 1.48

Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron Clin Pract (2005) 1.43

Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension (2003) 1.43

Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev (2012) 1.42

Effect of mild hyperisulinemia on conduit vessel endothelial function: role of noradrenergic activation. J Hypertens (2012) 1.42

Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up. Nephrol Dial Transplant (2011) 1.40

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA (2004) 1.40

Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. J Hypertens (2008) 1.39

[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39

Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens (2007) 1.36

The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol (2003) 1.33

Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab (2006) 1.29

Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol (2009) 1.27

The eye and the heart. Eur Heart J (2013) 1.18

Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol (2004) 1.17

Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol (2011) 1.16

Sleep loss and hypertension: a systematic review. Curr Pharm Des (2013) 1.15

Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension (2012) 1.15

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension (2003) 1.15

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Can J Physiol Pharmacol (2005) 1.12

Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev (2010) 1.11

Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs (2002) 1.11

Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07

Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol (2012) 1.06

Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol (2006) 1.05

Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. J Ultrasound Med (2010) 1.04

Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis. Free Radic Biol Med (2010) 1.02

Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension (2006) 1.02

Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens (2008) 1.02